Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in RPRX — Royalty Pharma plc

CIK 1692234 Seattle, WA
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$94,996,587
+$27,936,546 QoQ
Shares Held
1,694,250
+21.2% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#40
of 646 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 71% Shared 0% None 29%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. RPRX ranks #3 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
This page 		1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in RPRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $94,996,587 1,694,250
2026-03-31 $67,060,041 1,397,958
2025-12-31 $54,056,273 1,398,972
2025-09-30 $49,600,604 1,405,913
2025-06-30 $47,100,715 1,307,264
2025-03-31 $49,613,651 1,593,757
2024-12-31 $47,341,223 1,855,791
2024-09-30 $39,782,527 1,406,240
2024-06-30 $21,595,946 818,959
2024-03-31 $12,213,080 402,143
2023-12-31 $9,072,140 322,967
2023-09-30 $7,275,147 268,060
2023-06-30 $9,412,585 306,200
2023-03-31 $15,370,682 426,608
2022-12-31 $15,074,942 381,451
2022-09-30 $15,418,550 383,737
2022-06-30 $14,153,478 336,667
2022-03-31 $762,057 19,560
2021-12-31 $302,062 7,580
2021-09-30 $289,806 8,019
2021-06-30 $44,884 1,095
2021-03-31 $58,886 1,350
2020-12-31 $6,802,044 135,905
2020-09-30 $145,604 3,461